Laura Lorenzon, MD, PhD, Policlinico Universitario Agostino Gemelli, Rome, Italy discusses the importance of prioritizing patients’ quality of life in addition to clinical outcomes, particularly in the context of cancer treatment. She highlights that while clinicians often focus on survival rates and access to therapies, patients may be more concerned about their overall well-being during their treatment journey. This interview took place at the ESSO 43 congress in Antwerp, Belgium.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.